Johnson & Johnson is joining the ranks of companies providing access to its clinical trial data. But it is taking a different approach to the process, leaving it to a group at Yale School of Medicine to review and make final decisions on requests from investigators and physicians for access to anonymized data.
J&J announced on Jan. 30 that it has entered into an agreement with Yale School of Medicine’s Open Data Access...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?